These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators. Zhang S; Holmes AP; Dick A; Rashad AA; Enríquez Rodríguez L; Canziani GA; Root MJ; Chaiken IM Retrovirology; 2021 Oct; 18(1):31. PubMed ID: 34627310 [TBL] [Abstract][Full Text] [Related]
7. Peptide Triazole Inactivators of HIV-1 Utilize a Conserved Two-Cavity Binding Site at the Junction of the Inner and Outer Domains of Env gp120. Aneja R; Rashad AA; Li H; Kalyana Sundaram RV; Duffy C; Bailey LD; Chaiken I J Med Chem; 2015 May; 58(9):3843-58. PubMed ID: 25860784 [TBL] [Abstract][Full Text] [Related]
9. Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1. Gopi H; Umashankara M; Pirrone V; LaLonde J; Madani N; Tuzer F; Baxter S; Zentner I; Cocklin S; Jawanda N; Miller SR; Schön A; Klein JC; Freire E; Krebs FC; Smith AB; Sodroski J; Chaiken I J Med Chem; 2008 May; 51(9):2638-47. PubMed ID: 18402432 [TBL] [Abstract][Full Text] [Related]
10. Peptide triazole inactivators of HIV-1: how do they work and what is their potential? Chaiken I; Rashad AA Future Med Chem; 2015; 7(17):2305-10. PubMed ID: 26599515 [No Abstract] [Full Text] [Related]
12. Covalent conjugation of a peptide triazole to HIV-1 gp120 enables intramolecular binding site occupancy. Emileh A; Duffy C; Holmes AP; Rosemary Bastian A; Aneja R; Tuzer F; Rajagopal S; Li H; Abrams CF; Chaiken IM Biochemistry; 2014 Jun; 53(21):3403-14. PubMed ID: 24801282 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation. Rosemary Bastian A; Nangarlia A; Bailey LD; Holmes A; Kalyana Sundaram RV; Ang C; Moreira DR; Freedman K; Duffy C; Contarino M; Abrams C; Root M; Chaiken I J Biol Chem; 2015 Jan; 290(1):529-43. PubMed ID: 25371202 [TBL] [Abstract][Full Text] [Related]
14. Chemical optimization of macrocyclic HIV-1 inactivators for improving potency and increasing the structural diversity at the triazole ring. Rashad AA; Acharya K; Haftl A; Aneja R; Dick A; Holmes AP; Chaiken I Org Biomol Chem; 2017 Sep; 15(37):7770-7782. PubMed ID: 28770939 [TBL] [Abstract][Full Text] [Related]
15. Disulfide Sensitivity in the Env Protein Underlies Lytic Inactivation of HIV-1 by Peptide Triazole Thiols. Bailey LD; Kalyana Sundaram RV; Li H; Duffy C; Aneja R; Rosemary Bastian A; Holmes AP; Kamanna K; Rashad AA; Chaiken I ACS Chem Biol; 2015 Dec; 10(12):2861-73. PubMed ID: 26458166 [TBL] [Abstract][Full Text] [Related]
16. Macrocyclic Envelope Glycoprotein Antagonists that Irreversibly Inactivate HIV-1 before Host Cell Encounter. Rashad AA; Kalyana Sundaram RV; Aneja R; Duffy C; Chaiken I J Med Chem; 2015 Sep; 58(18):7603-8. PubMed ID: 26331669 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor. Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829 [TBL] [Abstract][Full Text] [Related]
18. Recognition of HIV-inactivating peptide triazoles by the recombinant soluble Env trimer, BG505 SOSIP.664. Acharya K; Rashad AA; Moraca F; Klasse PJ; Moore JP; Abrams C; Chaiken I Proteins; 2017 May; 85(5):843-851. PubMed ID: 28056499 [TBL] [Abstract][Full Text] [Related]
19. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions. Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033 [TBL] [Abstract][Full Text] [Related]
20. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120. Neffe AT; Meyer B Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309 [No Abstract] [Full Text] [Related] [Next] [New Search]